文献速递中毒与环境急症消化、代谢与肾脏急症

医用与成人用大麻法律与医疗补助参保者阿片类药物处方的关联

Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees.
PubMed 文献 · JAMA Intern Med · 2018-01-01
一句话结论2011至2016年实施医用大麻法律的州,医疗补助参保者阿片处方率降低5.88%(95%CI -11.55%至约-0.21%);实施成人用大麻法律的州降低6.38%(95%CI -12.20%至约-0.56%)。

该横截面研究采用准实验倍差法,比较2011至2016年间开始实施医用和成人用大麻法律的州与其余州之间医疗补助参保者的阿片处方趋势。研究对象为全美医疗补助按服务收费和管理式医疗参保者,属慢性疼痛、阿片使用障碍和阿片过量的高风险人群。结果显示,实施医用大麻法律与阿片处方率降低5.88%相关(95%CI -11.55%至约-0.21%),实施成人用大麻法律(均发生在已有医用大麻法律的州)与降低6.38%相关(95%CI -12.20%至约-0.56%)。作者认为,大麻自由化在降低医疗补助参保者处方阿片使用及其后果方面的潜力,值得在大麻改革和阿片流行病的政策讨论中予以考虑。

要点

  • 实施医用大麻法律的州,医疗补助参保者阿片处方率降低5.88%(95%CI -11.55%至约-0.21%)。
  • 实施成人用大麻法律的州(均已有医用大麻法律),阿片处方率降低6.38%(95%CI -12.20%至约-0.56%)。
  • 研究采用准实验倍差法,比较2011至2016年实施大麻法律的州与其余州的阿片处方趋势。
  • 研究对象为全美医疗补助按服务收费和管理式医疗参保者,属慢性疼痛、阿片使用障碍和阿片过量高风险人群。
  • 作者认为,大麻自由化降低处方阿片使用及其后果的潜力值得在政策讨论中考虑。

适用人群与场景

  • 全美医疗补助按服务收费和管理式医疗参保者,属慢性疼痛、阿片使用障碍和阿片过量高风险人群。
  • 比较2011至2016年间开始实施医用和成人用大麻法律的州与其余州。

研究设计与关键结果

  • 研究类型:横截面研究,采用准实验倍差法设计,比较2011至2016年开始实施医用和成人用大麻法律的州与其余州之间阿片处方趋势。
  • 主要结局:阿片处方率,按每季度每1000名医疗补助参保者中医疗补助覆盖的阿片处方数计算。
  • 实施医用大麻法律与阿片处方率降低5.88%相关(95%CI -11.55%至约-0.21%)。
  • 实施成人用大麻法律(均发生在已有医用大麻法律的州)与阿片处方率降低6.38%相关(95%CI -12.20%至约-0.56%)。

证据类型、等级与局限

  • 证据类型:横截面研究,准实验倍差法设计。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,大麻自由化在降低医疗补助参保者处方阿片使用及其后果方面的潜力,值得在大麻改革和阿片流行病的政策讨论中予以考虑。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Overprescribing of opioids is considered a major driving force behind the opioid epidemic in the United States. Marijuana is one of the potential nonopioid alternatives that can relieve pain at a relatively lower risk of addiction and virtually no risk of overdose. Marijuana liberalization, including medical and adult-use marijuana laws, has made marijuana available to more Americans.

OBJECTIVE: To examine the association of state implementation of medical and adult-use marijuana laws with opioid prescribing rates and spending among Medicaid enrollees.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used a quasi-experimental difference-in-differences design comparing opioid prescribing trends between states that started to implement medical and adult-use marijuana laws between 2011 and 2016 and the remaining states. This population-based study across the United States included all Medicaid fee-for-service and managed care enrollees, a high-risk population for chronic pain, opioid use disorder, and opioid overdose.

EXPOSURES: State implementation of medical and adult-use marijuana laws from 2011 to 2016.

MAIN OUTCOMES AND MEASURES: Opioid prescribing rate, measured as the number of opioid prescriptions covered by Medicaid on a quarterly, per-1000-Medicaid-enrollee basis.

RESULTS: State implementation of medical marijuana laws was associated with a 5.88% lower rate of opioid prescribing (95% CI, -11.55% to approximately -0.21%). Moreover, the implementation of adult-use marijuana laws, which all occurred in states with existing medical marijuana laws, was associated with a 6.38% lower rate of opioid prescribing (95% CI, -12.20% to approximately -0.56%).

CONCLUSIONS AND RELEVANCE: The potential of marijuana liberalization to reduce the use and consequences of prescription opioids among Medicaid enrollees deserves consideration during the policy discussions about marijuana reform and the opioid epidemic.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Wen H, Hockenberry JM. Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees. JAMA Intern Med. 2018. PMID: 29610827. doi:10.1001/jamainternmed.2018.1007

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。